CN Patent

CN105431144A — 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合

Assigned to Synchroneuron Inc · Expires 2016-03-23 · 10y expired

What this patent protects

本文公开的实施方案通常涉及阿坎酸制剂、使用该制剂的方法，涉及使用任选地与至少一种其他药剂组合的制剂的方法，并且涉及包含阿坎酸和至少一种其他药剂例如精神抑制药(抗精神病药)和/或抗抑郁药的组合产品和组合物。

USPTO Abstract

本文公开的实施方案通常涉及阿坎酸制剂、使用该制剂的方法，涉及使用任选地与至少一种其他药剂组合的制剂的方法，并且涉及包含阿坎酸和至少一种其他药剂例如精神抑制药(抗精神病药)和/或抗抑郁药的组合产品和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105431144A
Jurisdiction
CN
Classification
—
Expires
2016-03-23
Drug substance claim
No
Drug product claim
No
Assignee
Synchroneuron Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.